Literature DB >> 25901715

Prognostic role of BNP in children undergoing surgery for congenital heart disease: analysis of prediction models incorporating standard risk factors.

Massimiliano Cantinotti, Raffaele Giordano, Marco Scalese, Sabrina Molinaro, Francesca Della Pina, Simona Storti, Luigi Arcieri, Bruno Murzi, Marco Marotta, Vitali Pak, Vincenzo Poli, Giorgio Iervasi, Shelby Kutty, Aldo Clerico.   

Abstract

BACKGROUND: The routine use of brain natriuretic peptide (BNP) in pediatric cardiac surgery remains controversial. Our aim was to test whether BNP adds information to predict risk in pediatric cardiac surgery.
METHODS: In all, 587 children undergoing cardiac surgery (median age 6.3 months; 1.2-35.9 months) were prospectively enrolled at a single institution. BNP was measured pre-operatively, on every post-operative day in the intensive care unit, and before discharge. The primary outcome was major complications and length ventilator stay >15 days. A first risk prediction model was fitted using Cox proportional hazards model with age, body surface area and Aristotle score as continuous predictors. A second model was built adding cardiopulmonary bypass time and arterial lactate at the end of operation to the first model. Then, peak post-operative log-BNP was added to both models. Analysis to test discrimination, calibration, and reclassification were performed.
RESULTS: BNP increased after surgery (p<0.001), peaking at a mean of 63.7 h (median 36 h, interquartile range 12-84 h) post-operatively and decreased thereafter. The hazard ratios (HR) for peak-BNP were highly significant (first model HR=1.40, p=0.006, second model HR=1.44, p=0.008), and the log-likelihood improved with the addition of BNP at 12 h (p=0.006; p=0.009). The adjunction of peak-BNP significantly improved the area under the ROC curve (first model p<0.001; second model p<0.001). The adjunction of peak-BNP also resulted in a net gain in reclassification proportion (first model NRI=0.089, p<0.001; second model NRI=0.139, p=0.003).
CONCLUSIONS: Our data indicates that BNP may improve the risk prediction in pediatric cardiac surgery, supporting its routine use in this setting.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25901715     DOI: 10.1515/cclm-2014-1084

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  9 in total

Review 1.  Three-dimensional printed models in congenital heart disease.

Authors:  Massimiliano Cantinotti; Israel Valverde; Shelby Kutty
Journal:  Int J Cardiovasc Imaging       Date:  2016-09-27       Impact factor: 2.357

2.  Surgical strategy for tetralogy of Fallot with abnormal coronary arteries.

Authors:  Raffaele Giordano; Massimiliano Cantinotti; Luigi Di Tommaso; Gaetano Palma
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

3.  Mid-regional pro-adrenomedullin for diagnosing evolution after cardiac surgery in newborns: the PRONEW study.

Authors:  Sara Bobillo-Perez; Monica Girona-Alarcon; Debora Cañizo; Marta Camprubi-Camprubi; Javier Rodriguez-Fanjul; Monica Balaguer; Sergio Benito; Anna Valls; Francisco Jose Cambra; Iolanda Jordan
Journal:  Eur J Pediatr       Date:  2021-10-22       Impact factor: 3.183

4.  Risk Factors for Cardiac Adverse Events in Infants and Children with Complex Heart Disease Scheduled for Bi-ventricular Repair: Prognostic Value of Pre-operative B-Type Natriuretic Peptide and High-Sensitivity Troponin T.

Authors:  Yoshiki Mori; Yasumi Nakashima; Sachie Kaneko; Nao Inoue; Tomotaka Murakami
Journal:  Pediatr Cardiol       Date:  2020-08-17       Impact factor: 1.655

Review 5.  Cardiac biomarkers in pediatric heart disease: A state of art review.

Authors:  Benedict A Fernandes; Kevin O Maher; Shriprasad R Deshpande
Journal:  World J Cardiol       Date:  2016-12-26

6.  Impact of underlying heart disease per se on the utility of preoperative NT-proBNP in adult cardiac surgery.

Authors:  Huiqi Jiang; Henrik Hultkvist; Jonas Holm; Farkas Vanky; Yanqi Yang; Rolf Svedjeholm
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

7.  Prognostic value of biomarkers after cardiopulmonary bypass in pediatrics: The prospective PANCAP study.

Authors:  Sara Bobillo-Perez; Iolanda Jordan; Patricia Corniero; Monica Balaguer; Anna Sole-Ribalta; Maria Esther Esteban; Elisabeth Esteban; Francisco Jose Cambra
Journal:  PLoS One       Date:  2019-06-17       Impact factor: 3.240

8.  Prognostic value of perioperative NT-proBNP after corrective surgery for pediatric congenital heart defects.

Authors:  Fangqin Lin; Lingling Zheng; Yanqin Cui; Weidan Chen; Ramit Kumar Gupta; Huixian Li; Xinxin Chen; Huimin Xia; Huiying Liang
Journal:  BMC Pediatr       Date:  2019-12-16       Impact factor: 2.125

9.  Evaluation of Circulating Cardiovascular Biomarker Levels for Early Detection of Congenital Heart Disease in Newborns in Sweden.

Authors:  Henning Clausen; Elisabeth Norén; Salla Valtonen; Aki Koivu; Mikko Sairanen; Petru Liuba
Journal:  JAMA Netw Open       Date:  2020-12-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.